These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 16312501)

  • 21. A bronchoscopic scoring system for airway secretions--airway cellularity and microbiological validation.
    Chang AB; Faoagali J; Cox NC; Marchant JM; Dean B; Petsky HL; Masters IB
    Pediatr Pulmonol; 2006 Sep; 41(9):887-92. PubMed ID: 16858700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of different resistance traits on the competitive growth of Haemophilus influenzae in antibiotic-free medium and selection of resistant populations by different {beta}-lactams: an in vitro pharmacodynamic approach.
    González N; Aguilar L; Alou L; Giménez MJ; Sevillano D; Torrico M; Cafini F; Coronel P; Prieto J
    J Antimicrob Chemother; 2009 Jun; 63(6):1215-22. PubMed ID: 19307171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of allergic contact dermatitis to clavulanic acid.
    Kim YH; Ko JY; Kim YS; Ro YS
    Contact Dermatitis; 2008 Dec; 59(6):378-9. PubMed ID: 19076895
    [No Abstract]   [Full Text] [Related]  

  • 24. Combating resistance: application of the emerging science of pharmacokinetics and pharmacodynamics.
    Jacobs MR
    Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S122-6. PubMed ID: 17936592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of severe odontogenic infections with amoxicillin/clavulanic acid.
    Gerlach KL; Schaal KP; Walz C; Pape HD
    J Chemother; 1989 Jul; 1(4 Suppl):746-7. PubMed ID: 16312619
    [No Abstract]   [Full Text] [Related]  

  • 26. Activity and penetration of fosfomycin, ciprofloxacin, amoxicillin/clavulanic acid and co-trimoxazole in Escherichia coli and Pseudomonas aeruginosa biofilms.
    Rodríguez-Martínez JM; Ballesta S; Pascual A
    Int J Antimicrob Agents; 2007 Oct; 30(4):366-8. PubMed ID: 17616359
    [No Abstract]   [Full Text] [Related]  

  • 27. Susceptibility to amoxycillin-clavulanate among clinical isolates of Escherichia coli resistant to cefoxitin.
    Fernandez-Cuenca F; Martinez-Martinez L; Amblar G; Biedenbach DJ; Jones RN; Pascual A
    Clin Microbiol Infect; 2006 Feb; 12(2):197-8. PubMed ID: 16441464
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of respiratory tract infections with augmentin.
    Cioffi R; Turco D; Alfano B; Di Salvatore F; Gnasso P; Mastroianni S
    J Chemother; 1989 Jul; 1(4 Suppl):766-7. PubMed ID: 16312630
    [No Abstract]   [Full Text] [Related]  

  • 29. The clinical development and launch of amoxicillin/clavulanate for the treatment of a range of community-acquired infections.
    Ball P
    Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S113-7. PubMed ID: 17997283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic activity of amoxicillin/clavulanic acid and cefoxitin in vascular surgery--a randomized clinical study.
    Dieterich HJ; Behringer K; Lauterjung L; Peter K
    J Chemother; 1989 Jul; 1(4 Suppl):1059. PubMed ID: 16312770
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibiotic prophylaxis for orthognathic surgery: a prospective, comparative, randomized study between amoxicillin-clavulanic acid and penicillin.
    Jansisyanont P; Sessirisombat S; Sastravaha P; Bamroong P
    J Med Assoc Thai; 2008 Nov; 91(11):1726-31. PubMed ID: 19127796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of the efficacy of amoxicillin plus clavulanic acid in the treatment of ear, nose and throat infections.
    Ottaviani A; Pagano A; Sambataro G; Berto M; Lenzi A; Mascheroni E
    J Chemother; 1989 Jul; 1(4 Suppl):752-4. PubMed ID: 16312622
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of pharmacokinetic/pharmacodynamic principles to predict clinical outcome in paediatric acute otitis media.
    Dagan R
    Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S127-30. PubMed ID: 17980558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a twice daily dosing regimen of amoxicillin/clavulanate.
    Bax R
    Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S118-21. PubMed ID: 17983732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inactivation of viruses by secretions of the respiratory tract.
    ROSE HM; PRINCE EM
    J Clin Invest; 1948 Jul; 27(4):554. PubMed ID: 18873835
    [No Abstract]   [Full Text] [Related]  

  • 36. Prophylaxis versus pre-emptive treatment for infective and inflammatory complications of surgical third molar removal: a randomized, double-blind, placebo-controlled, clinical trial with sustained release amoxicillin/clavulanic acid (1000/62.5 mg).
    Lacasa JM; Jiménez JA; Ferrás V; Bossom M; Sóla-Morales O; García-Rey C; Aguilar L; Garau J
    Int J Oral Maxillofac Surg; 2007 Apr; 36(4):321-7. PubMed ID: 17229548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urine bactericidal activity against resistant Escherichia coli in an in vitro pharmacodynamic model simulating urine concentrations obtained after 2000/125 mg sustained-release co-amoxiclav and 400 mg norfloxacin administration.
    Alou L; Aguilar L; Sevillano D; Giménez MJ; Cafini F; Valero E; Relaño MT; Prieto J
    J Antimicrob Chemother; 2006 Apr; 57(4):714-9. PubMed ID: 16492718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formation of rectus sheath hematoma with antibiotic use and warfarin therapy: a case report.
    Kelly M; Moran J; Byrne S
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):266-9. PubMed ID: 16503323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of parenteral amoxycillin/ clavulanate for prevention of surgical site infection following abdominal surgery.
    Lohsiriwat D; Chinswangwatanakul V; Lohsiriwat V; Leelaratsamee A
    J Med Assoc Thai; 2009 Sep; 92(9):1167-70. PubMed ID: 19772175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Childhood linear IgA bullous disease triggered by amoxicillin-clavulanic acid.
    Ho JC; Ng PL; Tan SH; Giam YC
    Pediatr Dermatol; 2007; 24(5):E40-3. PubMed ID: 17958778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.